Search results
Levi & Korsinsky Notifies Shareholders of bluebird bio, Inc.(BLUE) of a Class Action Lawsuit and an...
FOX 5 San Diego· 8 hours agoLevi & Korsinsky, LLP notifies investors in bluebird bio, Inc. ("bluebird bio" or the "Company") (NASDAQ: BLUE) of ...
A company insider recently sold 6,095 shares of Bluebird bio Inc [BLUE]. Should You also Consider to...
Knox Daily· 17 hours agoBluebird bio Inc’s filing revealed that its President and CEO Obenshain Andrew unloaded Company’s shares for reported $9311.0 on Mar 04 ’24. In the deal ...
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in bluebird bio, Inc. with Losses...
WFRV 5 Green Bay· 7 hours agoThe Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class...
Bluebird bio Inc: Is BLUE Stock Worth Buying? – Stocks Register
Stocks Register· 1 day agoThe trading price of Bluebird bio Inc (NASDAQ:BLUE) closed lower on Monday, May 13, closing at $1.02, -3.77% lower than its previous close. In examining ...
Earnings call: Bluebird bio reports Q1 2024 results, anticipates growth By Investing.com
Investing.com· 6 days agoBluebird bio Inc. (BLUE) has announced its first-quarter 2024 financial results, highlighting the...
bluebird bio, Inc. (NASDAQ:BLUE) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agobluebird bio, Inc. (NASDAQ:BLUE) Q1 2024 Earnings Call Transcript May 9, 2024 bluebird bio, Inc....
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel...
WKRN Nashville· 21 hours agoWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of bluebird bio, Inc. (NASDAQ: BLUE) between April 24, 2023 and ...
bluebird bio Inc (BLUE) Q1 2024 Earnings: Surpasses Revenue Expectations with Strategic Focus ...
GuruFocus.com via Yahoo Finance· 5 days agoOn May 9, 2024, bluebird bio Inc (NASDAQ:BLUE), a leader in gene therapy innovation, released its first quarter financial results through an 8-K filing.
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
WCBD-TV Charleston· 7 days agoLaw Offices of Howard G. Smith announces that investors with substantial losses have opportunity to...
...Investors of Looming Deadline in the Class Action Lawsuit Against bluebird bio, Inc. (BLUE) - ...
Benzinga· 5 days agoYou can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights. On December 8, 2023, bluebird ...